Marc Cobo
Chief Accounting Officer
BridgeBio Oncology Therapeutics, Inc. (BBOT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Marc Cobo
Marc Cobo is recorded as Chief Accounting Officer at BridgeBio Oncology Therapeutics, Inc. (BBOT). BridgeBio Oncology Therapeutics, Inc. reported in an 8-K filed April 23, 2026 that Marc Cobo was appointed principal accounting officer, effective April 21, 2026.
“Effective April 21, 2026, the Company’s Board of Directors appointed Mr. Elmelech as the Company’s principal financial officer and Marc Cobo, the Company’s Vice President of Finance and Controller, as the Company’s principal accounting officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-04-21–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at BridgeBio Oncology Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Eli Wallace CEO, Board Member
- Pedro Beltran, Ph.D. CEO, Board Member
- Pedro J. Beltran, Ph.D. CEO, Board Member
- Neil Kumar, Ph.D. Chairman
- Idan Elmelech CFO, COO, Board Member
- Uneek Mehra CFO
- Albert A. Holman, III Board Member
- Bihua Chen Board Member
- Frank McCormick Board Member
- Frank P. McCormick Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.